BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 18662740)

  • 1. Hepatic fibrosis -- overview.
    Friedman SL
    Toxicology; 2008 Dec; 254(3):120-9. PubMed ID: 18662740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stellate cell activation in alcoholic fibrosis--an overview.
    Friedman SL
    Alcohol Clin Exp Res; 1999 May; 23(5):904-10. PubMed ID: 10371412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis.
    Novo E; di Bonzo LV; Cannito S; Colombatto S; Parola M
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2089-93. PubMed ID: 19782946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R; Brenner DA
    Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
    Friedman SL
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis.
    Wallace K; Burt AD; Wright MC
    Biochem J; 2008 Apr; 411(1):1-18. PubMed ID: 18333835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types.
    Saile B; Ramadori G
    Z Gastroenterol; 2007 Jan; 45(1):77-86. PubMed ID: 17236124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fibrosis--role of hepatic stellate cell activation.
    Safadi R; Friedman SL
    MedGenMed; 2002 Jul; 4(3):27. PubMed ID: 12466770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques.
    Tacke F; Weiskirchen R
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):67-80. PubMed ID: 22149583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G; De Minicis S; Marzioni M
    Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver extracellular matrix in health and disease.
    Bedossa P; Paradis V
    J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.